Table 6.
Account of Interaction to the Phenotypic F2 Variance for Every Trait
| BW Position | Position effect (%) | C9–61 0.5 | C11–48 6.1 | C14–52 0.3 | C15–58 0.9 | C17–47 0.3 | C18–50 0.3 | CX–16 0.5 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| C1–82 | 2.1 | 4.8 | |||||||||
| C2–9 | 1.3 | 3.7 | |||||||||
| C2–13 | 0.9 | 3.9 | |||||||||
| C5–81 | 5.8 | 4.2 | |||||||||
| C11–14 | 3.6 | 4.6 | |||||||||
| C14–20 | 0.7 | 3.8 | |||||||||
| C14–28 | 1.0 | 4.1 | |||||||||
| C17–7 | 0.2 | 5.1 | |||||||||
| C18–50 | 0.5 | 4.5 | |||||||||
| AFW Position | Position effect (%) | C11–58 3.0 | C12–16 2.9 | C14–3 0.3 | C15–58 0.2 | C17–47 4.7 | C17–57 4.5 | C18–50 1.0 | C19–47 0.6 | CX–16 1.4 | |
| C2–13 | 1.1 | 3.8 | |||||||||
| C4–66 | 0.5 | 3.7 | |||||||||
| C5–81 | 3.5 | 5.2 | |||||||||
| C10–40 | 0.0 | 3.8 | |||||||||
| C11–1 | 1.0 | 4.4 | |||||||||
| C11–14 | 1.7 | 3.9 | |||||||||
| C11–48 | 1.8 | 3.6 | |||||||||
| C11–79 | 0.5 | 4.2 | |||||||||
| C13–61 | 0.0 | 4.4 | |||||||||
| C14–44 | 0.6 | 4.3 | 4.1 | ||||||||
| C16–17 | 0.2 | 4.0 | |||||||||
| MW Position | Position effect (%) | C7–16 9.4 | C7–37 9.4 | C14–28 0.2 | C14–52 0.2 | C16–17 0.2 | C16–38 0.5 | CX–16 0.8 | |||
| C2–9 | 1.1 | 4.3 | |||||||||
| C2–75 | 0.0 | 4.2 | |||||||||
| C4–56 | 0.8 | 4.3 | |||||||||
| C7–16 | 9.4 | 4.0 | |||||||||
| C9–28 | 1.8 | 3.7 | |||||||||
| C11–37 | 4.9 | 3.8 | |||||||||
| C18–50 | 0.2 | 4.1 | |||||||||
| Leptin Position | Position effect (%) | C5–81 2.7 | C11–37 0.9 | C15–49 0.1 | C16–38 0.3 | C17–47 0.6 | C19–47 3.2 | CX–16 0.1 | |||
| C1–82 | 2.0 | 4.9 | |||||||||
| C2–75 | 0.6 | 5.0 | |||||||||
| C9–28 | 0.3 | 4.3 | |||||||||
| C9–61 | 0.2 | 8.9 | |||||||||
| C14–20 | 2.1 | 4.6 | |||||||||
| C14–44 | 1.5 | 4.5 | |||||||||
| C18–50 | 1.3 | 4.4 | |||||||||
| Insulin Position | Position effect (%) | C4–66 3.3 | C11–14 0.5 | C15–6 1.5 | C17–57 1.3 | C18–50 0.2 | |||||
| C2–9 | 0.9 | 4.5 | |||||||||
| C4–56 | 2.8 | 4.9 | 6.7 | ||||||||
| C7–37 | 2.4 | 4.3 | |||||||||
| C14–28 | 0.9 | 4.6 | |||||||||
| IGF-I Position | Positive effect (%) | C2–60 1.6 | C2–109 0.3 | C11–1 0.2 | C13–61 0.1 | C14–20 0.2 | C14–28 0.5 | C15–6 0.6 | C15–26 0.9 | C15–49 0.8 | C17–57 1.8 |
| C1–9 | 2.7 | 4.8 | |||||||||
| C1–43 | 0.3 | 6.3 | |||||||||
| C2–13 | 0.3 | 4.5 | 3.9 | ||||||||
| C7–37 | 0.7 | 6.0 | |||||||||
| C10–40 | 14.3 | 4.6 | 5.4 | 4.2 | |||||||
| C14–44 | 0.2 | 8.8 | |||||||||
| C14–52 | 0.9 | 4.6 |
The contingency tables for body weight (BW), abdominal fat weight (AFW), muscle weight (MW), and the serum levels of leptin, insulin, and IGF-I present significant effects (P < 0.01) of the locus*locus interaction on every trait. The direct effect of a marker on a trait is given below the marker in the heading and behind the marker in the left column. Significant direct effects at 0.01 are marked bold. The direct marker effects on the F2 variance of a trait are given as reduction of the residual sum of squares with and without direct marker effect in the model. The effect of the locus*locus interaction was estimated as the reduction of the residual sum of squares with and without interaction effects in the model. Empty columns and rows were deleted from the contingency tables. Interaction effects exceeding P < 0.001 significance are framed.